Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   septicemia
  

Disease ID 1592
Disease septicemia
Definition
systemic disease associated with presence and persistance of pathogenic microorganisms or their toxins in the blood.
Synonym
(septicaemia nos) or (sepsis)
(septicaemia nos) or (sepsis) (disorder)
(septicemia nos) or (sepsis)
[x]septicaemia, unspecified
[x]septicemia, unspecified
[x]septicemia, unspecified (disorder)
blood pois
blood poisoning, nos
blood poisonings
pois blood
poisoning blood
poisoning, blood
poisonings, blood
sepsis
sepsis syndrome
septicaemia
septicaemia (disorder)
septicaemia nos
septicaemia, nos
septicemia (disorder)
septicemia [disease/finding]
septicemia nos
septicemia nos (disorder)
septicemia, nos
septicemias
unspecified septicemia
UMLS
C0036690
MeSH
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:349)
C0032285  |  pneumonia  |  75
C0027947  |  neutropenia  |  39
C0012739  |  disseminated intravascular coagulation  |  29
C0004623  |  bacterial infection  |  26
C0031154  |  peritonitis  |  25
C1704437  |  respiratory distress syndrome  |  25
C0035078  |  renal failure  |  24
C0025289  |  meningitis  |  23
C0011847  |  diabetes  |  22
C0040034  |  thrombocytopenia  |  21
C0035222  |  acute respiratory distress syndrome  |  19
C0022660  |  acute renal failure  |  17
C0025229  |  melioidosis  |  17
C0023890  |  cirrhosis  |  16
C0034186  |  pyelonephritis  |  12
C0023418  |  leukemia  |  12
C0022116  |  ischemia  |  12
C0242966  |  systemic inflammatory response syndrome  |  12
C1145670  |  respiratory failure  |  12
C0040053  |  thrombosis  |  12
C0011570  |  depression  |  11
C0008495  |  chorioamnionitis  |  10
C0004623  |  bacterial infections  |  10
C0012739  |  disseminated intravascular coagulation (dic)  |  9
C0029443  |  osteomyelitis  |  9
C0020456  |  hyperglycemia  |  9
C0032285  |  pneumoniae  |  9
C0014118  |  endocarditis  |  9
C0242966  |  systemic inflammatory response syndrome (sirs)  |  7
C0030305  |  pancreatitis  |  7
C0003615  |  appendicitis  |  7
C0162429  |  malnourished  |  7
C0024530  |  malaria  |  7
C0023890  |  liver cirrhosis  |  7
C0008311  |  cholangitis  |  7
C0011849  |  diabetes mellitus  |  7
C0002871  |  anemia  |  6
C0020538  |  hypertension  |  6
C0022672  |  acute tubular necrosis  |  6
C0018801  |  heart failure  |  6
C0026846  |  muscle wasting  |  5
C0023467  |  acute myeloid leukemia  |  5
C0023470  |  myeloid leukemia  |  5
C0020598  |  hypoglycemia  |  5
C0878544  |  cardiomyopathy  |  5
C0034065  |  pulmonary embolism  |  5
C0238124  |  necrotizing fasciitis  |  5
C0023448  |  lymphoblastic leukemia  |  5
C0001623  |  adrenal insufficiency  |  5
C1565489  |  renal insufficiency  |  5
C0015645  |  fasciitis  |  5
C0085650  |  purpura fulminans  |  5
C0023449  |  acute lymphoblastic leukemia  |  5
C0034150  |  purpura  |  5
C0022661  |  end-stage renal disease  |  4
C0162429  |  malnutrition  |  4
C0035222  |  adult respiratory distress syndrome  |  4
C0519030  |  klebsiella pneumonia  |  4
C0085669  |  acute leukemia  |  4
C0085693  |  acute appendicitis  |  4
C0003873  |  rheumatoid arthritis  |  4
C0023895  |  liver disease  |  4
C0024312  |  lymphopenia  |  4
C0003864  |  arthritis  |  4
C0002766  |  analgesia  |  4
C0020538  |  hypertensive disorder  |  4
C0021053  |  immune dysfunction  |  4
C0011334  |  caries  |  4
C0028754  |  obesity  |  4
C0007642  |  cellulitis  |  3
C0026946  |  fungal infection  |  3
C0041296  |  tuberculosis  |  3
C1258215  |  ileus  |  3
C0024141  |  systemic lupus erythematosus  |  3
C0027051  |  myocardial infarction  |  3
C0040046  |  thrombophlebitis  |  3
C0032914  |  preeclampsia  |  3
C0024299  |  lymphoma  |  3
C0155765  |  microangiopathy  |  3
C0009324  |  ulcerative colitis  |  3
C0033687  |  proteinuria  |  3
C0003175  |  anthrax  |  3
C0376545  |  hematologic malignancies  |  3
C0022661  |  chronic kidney disease  |  3
C0014236  |  endophthalmitis  |  3
C0030312  |  pancytopenia  |  3
C0041466  |  typhoid  |  3
C0004626  |  bacterial pneumonia  |  3
C0002871  |  anaemia  |  3
C0027051  |  myocardial infarct  |  3
C0022658  |  renal disease  |  3
C0019158  |  hepatitis  |  3
C0025303  |  meningococcal disease  |  3
C0600327  |  toxic shock syndrome  |  3
C0520459  |  necrotizing enterocolitis  |  3
C0442874  |  neuropathy  |  3
C0520575  |  acute pyelonephritis  |  3
C0009319  |  colitis  |  3
C0409974  |  lupus erythematosus  |  3
C0497327  |  dementia  |  3
C0024115  |  lung disease  |  3
C0032285  |  lung inflammation  |  3
C0008370  |  cholestasis  |  2
C0009806  |  constipation  |  2
C0027059  |  myocarditis  |  2
C0003486  |  aortic aneurysm  |  2
C0030809  |  pemphigus vulgaris  |  2
C0030807  |  pemphigus  |  2
C0023530  |  leucopenia  |  2
C0001125  |  lactic acidosis  |  2
C0021400  |  influenza  |  2
C0001339  |  acute pancreatitis  |  2
C0019061  |  hemolytic uremic syndrome  |  2
C0023364  |  leptospirosis  |  2
C0022658  |  kidney disease  |  2
C0162529  |  ischemic colitis  |  2
C0026764  |  multiple myeloma  |  2
C0022876  |  preterm labor  |  2
C0025064  |  mediastinitis  |  2
C0027030  |  myiasis  |  2
C0025303  |  meningococcal infection  |  2
C0025162  |  toxic megacolon  |  2
C0024291  |  hemophagocytic syndrome  |  2
C0006840  |  candidiasis  |  2
C0020542  |  pulmonary hypertension  |  2
C0003177  |  cutaneous anthrax  |  2
C0272286  |  immune thrombocytopenia  |  2
C0021843  |  intestinal obstruction  |  2
C0035204  |  respiratory disease  |  2
C0035078  |  kidney failure  |  2
C0027868  |  neuromuscular disorders  |  2
C0024312  |  lymphocytopenia  |  2
C0018802  |  congestive heart failure  |  2
C0021843  |  bowel obstruction  |  2
C0023529  |  periventricular leukomalacia  |  2
C0026946  |  fungal infections  |  2
C0018801  |  cardiac failure  |  2
C0011991  |  diarrhea  |  2
C0026848  |  muscular disorders  |  2
C0042769  |  virus infection  |  2
C0035229  |  respiratory insufficiency  |  2
C0040053  |  thrombus  |  2
C0026846  |  muscle atrophy  |  2
C0032290  |  aspiration pneumonia  |  2
C0014121  |  infective endocarditis  |  2
C0008325  |  cholecystitis  |  2
C0679466  |  cognitive deficits  |  2
C0398625  |  protein c deficiency  |  2
C0155862  |  pneumococcal pneumonia  |  2
C0006287  |  chronic lung disease of prematurity  |  1
C0019829  |  hodgkin's disease  |  1
C0018802  |  congestive cardiac failure  |  1
C0017178  |  gastrointestinal disorders  |  1
C0025309  |  meningoencephalitis  |  1
C0006818  |  campylobacter infection  |  1
C0553662  |  juvenile idiopathic arthritis  |  1
C0920156  |  biliary tract infection  |  1
C0029882  |  otitis media  |  1
C0020676  |  hypothyroidism  |  1
C0023891  |  alcoholic liver cirrhosis  |  1
C0020295  |  hydronephrosis  |  1
C0020598  |  hypoglycaemia  |  1
C0011991  |  diarrhoea  |  1
C0018799  |  cardiac disease  |  1
C0014122  |  infectious endocarditis  |  1
C0022806  |  kwashiorkor  |  1
C0012739  |  consumptive coagulopathy  |  1
C0019151  |  hepatic encephalopathy  |  1
C0042769  |  viral disease  |  1
C0019069  |  haemophilia  |  1
C0041471  |  typhus  |  1
C0037998  |  splenic infarction  |  1
C1135868  |  gestational trophoblastic disease  |  1
C0011854  |  insulin dependent diabetes  |  1
C0018799  |  heart disease  |  1
C0023860  |  listeria infection  |  1
C0085096  |  peripheral vascular disease  |  1
C0014867  |  esophageal varices  |  1
C0023443  |  hairy cell leukemia  |  1
C1261473  |  soft tissue sarcomas  |  1
C0006112  |  metabolic encephalopathy  |  1
C0021845  |  intestinal perforation  |  1
C0032914  |  toxemia  |  1
C0010692  |  cystitis  |  1
C0036472  |  scrub typhus  |  1
C0032285  |  pneumonias  |  1
C0021845  |  bowel perforation  |  1
C0034072  |  pulmonary heart disease  |  1
C0023890  |  hepatic cirrhosis  |  1
C0036992  |  short bowel syndrome  |  1
C0033822  |  pseudomyxoma peritonei  |  1
C0392525  |  nephrolithiasis  |  1
C0033581  |  prostatitis  |  1
C0014859  |  esophageal cancer  |  1
C0024117  |  chronic obstructive pulmonary disease  |  1
C0042870  |  vitamin d deficiency  |  1
C0038012  |  spondylitis  |  1
C0017178  |  gastrointestinal disease  |  1
C0024115  |  pulmonary disease  |  1
C0041948  |  uremia  |  1
C0001824  |  agranulocytosis  |  1
C0009402  |  colorectal cancer  |  1
C0006285  |  bronchopneumonia  |  1
C0085160  |  hidradenitis  |  1
C0019202  |  wilson's disease  |  1
C0600260  |  obstructive pulmonary disease  |  1
C0006840  |  candida infection  |  1
C0853105  |  carcinoma of the penis  |  1
C0023449  |  acute lymphocytic leukaemia  |  1
C0026848  |  myopathies  |  1
C0034063  |  pulmonary edema  |  1
C0021831  |  intestinal disease  |  1
C0021400  |  influenzae  |  1
C0019569  |  hirschsprung's disease  |  1
C0030326  |  panniculitis  |  1
C0031117  |  peripheral neuropathy  |  1
C0007113  |  rectal cancer  |  1
C0034362  |  q fever  |  1
C0376545  |  hematological malignancies  |  1
C0178879  |  obstructive uropathy  |  1
C0042133  |  uterine leiomyomata  |  1
C0015230  |  rash  |  1
C0007102  |  colon cancer  |  1
C0152025  |  polyneuropathy  |  1
C0032326  |  pneumothorax  |  1
C0701818  |  choledocholithiasis  |  1
C0011860  |  type 2 diabetes  |  1
C0006666  |  calciphylaxis  |  1
C0343525  |  lemierre's syndrome  |  1
C0023470  |  myeloid leukemias  |  1
C0001261  |  actinomycosis  |  1
C0023418  |  leukemias  |  1
C0027086  |  myoma  |  1
C0043092  |  wegener's granulomatosis  |  1
C0017636  |  glioblastoma  |  1
C0022660  |  acute kidney failure  |  1
C0035222  |  adult respiratory distress syndrome (ards)  |  1
C0235974  |  pancreas cancer  |  1
C1956257  |  pulmonary stenosis  |  1
C0021053  |  immune disorders  |  1
C0014733  |  erysipelas  |  1
C0030567  |  parkinson's disease  |  1
C0162836  |  hidradenitis suppurativa  |  1
C0014121  |  bacterial endocarditis  |  1
C0017168  |  gastro-esophageal reflux  |  1
C0334634  |  mantle cell lymphoma  |  1
C0006840  |  candida infections  |  1
C0087086  |  thrombi  |  1
C0004623  |  bacterial disease  |  1
C0027726  |  nephrotic syndrome  |  1
C0025048  |  meconium aspiration  |  1
C0276026  |  haemophilus influenzae pneumonia  |  1
C0004936  |  mental disorders  |  1
C0019212  |  hepatorenal syndrome  |  1
C0039103  |  synovitis  |  1
C0023467  |  acute myeloid leukaemia  |  1
C0007137  |  squamous cell cancer  |  1
C0024894  |  mastitis  |  1
C0010414  |  cryptococcosis  |  1
C0019100  |  dengue haemorrhagic fever  |  1
C0020541  |  portal hypertension  |  1
C0042133  |  uterine leiomyoma  |  1
C0022658  |  nephropathy  |  1
C0026764  |  myeloma  |  1
C0011334  |  dental caries  |  1
C0030446  |  paralytic ileus  |  1
C0343525  |  lemierre syndrome  |  1
C0024110  |  lung abscess  |  1
C0027086  |  myomas  |  1
C0023281  |  leishmaniasis  |  1
C0038220  |  status epilepticus  |  1
C0021933  |  intussusception  |  1
C0017658  |  glomerulonephritis  |  1
C0238425  |  sickle cell crisis  |  1
C0006111  |  brain disorder  |  1
C0040034  |  thrombopenia  |  1
C0270612  |  leukoencephalopathy  |  1
C0026986  |  myelodysplastic syndrome  |  1
C0410528  |  skeletal dysplasia  |  1
C0041351  |  tularemia  |  1
C0240803  |  cerebral lymphoma  |  1
C0025306  |  meningococcemia  |  1
C0041327  |  pulmonary tb  |  1
C0025958  |  microcephaly  |  1
C0038463  |  strongyloides infection  |  1
C0158935  |  congenital pneumonia  |  1
C0376545  |  hematologic malignancy  |  1
C0011269  |  vascular dementia  |  1
C0022354  |  cholestatic jaundice  |  1
C0003460  |  anuria  |  1
C0022610  |  kernicterus  |  1
C0016952  |  galactosemia  |  1
C0040127  |  thyroid storm  |  1
C0002895  |  sickle cell disease  |  1
C0032300  |  lobar pneumonia  |  1
C0014013  |  pleural empyema  |  1
C0017920  |  g6pd deficiency  |  1
C0025306  |  meningococcal sepsis  |  1
C0153446  |  anal cancer  |  1
C0019187  |  alcoholic hepatitis  |  1
C0023452  |  childhood acute lymphoblastic leukemia  |  1
C1378050  |  oncocytoma  |  1
C0029408  |  osteoarthritis  |  1
C0001263  |  abdominal actinomycosis  |  1
C0034072  |  cor pulmonale  |  1
C0023448  |  lymphocytic leukaemia  |  1
C0042870  |  vitamin d defic  |  1
C0024225  |  lymphangitis  |  1
C0011880  |  diabetic ketoacidosis  |  1
C0042769  |  viral diseases  |  1
C0025160  |  megacolon  |  1
C0152965  |  staphylococcal bacteremia  |  1
C0037315  |  sleep apnoea  |  1
C0948265  |  metabolic syndrome  |  1
C0031046  |  pericarditis  |  1
C0242379  |  lung cancer  |  1
C0700101  |  urethral ca  |  1
C0023290  |  visceral leishmaniasis  |  1
C0011334  |  cavities  |  1
C0002395  |  alzheimer's disease  |  1
C0034155  |  thrombotic thrombocytopenic purpura  |  1
C0014850  |  esophageal atresia  |  1
C1261473  |  soft tissue sarcoma  |  1
C0031111  |  periostitis  |  1
C0021053  |  immune disease  |  1
C0020538  |  hypertensive disease  |  1
C0036202  |  sarcoid  |  1
C0086543  |  cataracts  |  1
C0085697  |  chronic pyelonephritis  |  1
C0085642  |  livedo reticularis  |  1
C0019048  |  hemoglobinuria  |  1
C0006287  |  bronchopulmonary dysplasia  |  1
C0042373  |  vascular disease  |  1
C0013418  |  abnormal labor  |  1
C0042075  |  uropathy  |  1
C0027051  |  myocardial infarction (mi)  |  1
C0024305  |  non-hodgkin lymphoma  |  1
C0017178  |  gastrointestinal disorder  |  1
C0152018  |  cancer of the esophagus  |  1
C0002874  |  aplastic anaemia  |  1
C0155773  |  portal vein thrombosis  |  1
C0015469  |  facial paralysis  |  1
C0042345  |  varices  |  1
C0017168  |  esophageal reflux  |  1
C0021053  |  immune disorder  |  1
C0085437  |  bacterial meningitis  |  1
C0019829  |  hodgkin lymphoma  |  1
C0010674  |  cystic fibrosis  |  1
C0023895  |  liver diseases  |  1
Curated Gene(Waiting for update.)
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:42)
671  |  BPI  |  infer
84433  |  CARD11  |  infer
929  |  CD14  |  infer
1511  |  CTSG  |  infer
2920  |  CXCL2  |  infer
1672  |  DEFB1  |  infer
2162  |  F13A1  |  infer
2153  |  F5  |  infer
2244  |  FGB  |  infer
3303  |  HSPA1A  |  infer
3304  |  HSPA1B  |  infer
3306  |  HSPA2  |  infer
3458  |  IFNG  |  infer
3586  |  IL10  |  infer
3606  |  IL18  |  infer
3552  |  IL1A  |  infer
3553  |  IL1B  |  infer
3554  |  IL1R1  |  infer
3557  |  IL1RN  |  infer
3569  |  IL6  |  infer
3654  |  IRAK1  |  infer
391179  |  KRT18P32  |  infer
3929  |  LBP  |  infer
4049  |  LTA  |  infer
4153  |  MBL2  |  infer
4282  |  MIF  |  infer
4488  |  MSX2  |  infer
137814  |  NKX2-6  |  infer
10544  |  PROCR  |  infer
5937  |  RBMS1  |  infer
100271033  |  RPL4P6  |  infer
645656  |  RPSAP56  |  infer
5054  |  SERPINE1  |  infer
6648  |  SOD2  |  infer
83930  |  STARD3NL  |  infer
7096  |  TLR1  |  infer
7099  |  TLR4  |  infer
7124  |  TNF  |  infer
7132  |  TNFRSF1A  |  infer
7133  |  TNFRSF1B  |  infer
54210  |  TREM1  |  infer
222052  |  TTC4P1  |  infer
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1592
Disease septicemia
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:261)
HP:0002090  |  Pneumonia  |  71
HP:0002615  |  Low blood pressure  |  62
HP:0001919  |  Acute renal failure  |  58
HP:0001945  |  Fever  |  45
HP:0001875  |  Neutropenia  |  38
HP:0002098  |  Respiratory distress  |  29
HP:0005521  |  Disseminated intravascular coagulation  |  28
HP:0002586  |  Peritonitis  |  25
HP:0000083  |  Renal insufficiency  |  25
HP:0001873  |  Low platelet count  |  22
HP:0001287  |  Meningitis  |  20
HP:0003256  |  Coagulopathy  |  17
HP:0001394  |  Hepatic cirrhosis  |  15
HP:0012330  |  Pyelonephritis  |  12
HP:0001298  |  Encephalopathy  |  12
HP:0001909  |  Leukemia  |  12
HP:0000716  |  Depression  |  11
HP:0002878  |  Respiratory failure  |  11
HP:0002754  |  Bone infection  |  11
HP:0001635  |  Congestive heart failure  |  9
HP:0001903  |  Anemia  |  9
HP:0100543  |  Cognitive deficits  |  9
HP:0002835  |  Aspiration  |  9
HP:0003074  |  High blood glucose  |  9
HP:0100584  |  Endocarditis  |  9
HP:0001941  |  acidemia  |  8
HP:0100758  |  Gangrene  |  8
HP:0004387  |  Enterocolitis  |  8
HP:0002664  |  Neoplasia  |  8
HP:0003202  |  Neurogenic muscle atrophy, especially in the lower limbs  |  8
HP:0002045  |  Abnormally low body temperature  |  8
HP:0000952  |  Yellow skin  |  7
HP:0000010  |  Frequent urinary tract infections  |  7
HP:0000819  |  Diabetes mellitus  |  7
HP:0011675  |  Arrhythmias  |  7
HP:0001410  |  Decreased liver function  |  7
HP:0001399  |  Liver failure  |  7
HP:0003287  |  Abnormality of mitochondrial metabolism  |  7
HP:0000822  |  Hypertension  |  6
HP:0001733  |  Pancreatic inflammation  |  6
HP:0001888  |  Lymphocytopenia  |  6
HP:0001297  |  Cerebral vascular events  |  6
HP:0008682  |  Renal tubular necrosis  |  6
HP:0001943  |  Hypoglycemia  |  6
HP:0011947  |  Respiratory infection  |  6
HP:0030151  |  Cholangitis  |  6
HP:0100523  |  Hepatic abscess  |  5
HP:0000846  |  Hypoadrenalism  |  5
HP:0002204  |  Pulmonary embolism  |  5
HP:0012324  |  Myeloid leukemia  |  5
HP:0011106  |  Depleted blood volume  |  5
HP:0001638  |  Cardiomyopathy  |  5
HP:0000855  |  Insulin resistance  |  5
HP:0000969  |  Dropsy  |  5
HP:0001944  |  Dehydration  |  5
HP:0006721  |  Acute lymphocytic leukemia  |  5
HP:0004808  |  Acute myelogenous leukemia  |  5
HP:0000670  |  Dental caries  |  4
HP:0005214  |  Bowel obstruction  |  4
HP:0003774  |  End-stage renal failure  |  4
HP:0002488  |  Acute leukemias  |  4
HP:0001518  |  Small for gestational age  |  4
HP:0001369  |  Arthritis  |  4
HP:0030005  |  Capillary leak  |  4
HP:0003073  |  Hypoalbuminaemia  |  4
HP:0100537  |  Inflammation of the fascia  |  4
HP:0001370  |  Rheumatoid arthritis  |  4
HP:0001513  |  Obesity  |  4
HP:0001649  |  Tachycardia  |  4
HP:0001942  |  Metabolic acidosis  |  4
HP:0002721  |  Immunodeficiency  |  4
HP:0001974  |  Leukocytosis  |  4
HP:0000979  |  Purpura  |  4
HP:0002104  |  Absence of spontaneous respiration  |  3
HP:0100279  |  Ulcerative colitis  |  3
HP:0004418  |  Thrombophlebitis  |  3
HP:0001876  |  Low blood cell count  |  3
HP:0100602  |  Pre-eclampsia  |  3
HP:0002725  |  Systemic lupus erythematosus  |  3
HP:0002904  |  High blood bilirubin levels  |  3
HP:0006532  |  Pneumonia, recurrent episodes  |  3
HP:0004395  |  Malnutrition  |  3
HP:0001324  |  Muscular weakness  |  3
HP:0030049  |  Brain abscess  |  3
HP:0100819  |  Intestinal fistula  |  3
HP:0002583  |  Colitis  |  3
HP:0002617  |  Aneurysmal dilatation  |  3
HP:0001658  |  Myocardial infarction  |  3
HP:0012115  |  Liver inflammation  |  3
HP:0006528  |  Chronic lung disease  |  3
HP:0002665  |  Lymphoma  |  3
HP:0000093  |  Proteinuria  |  3
HP:0002595  |  Gastrointestinal atony  |  3
HP:0002917  |  Low blood magnesium levels  |  3
HP:0006689  |  Bacterial endocarditis  |  3
HP:0100658  |  Bacterial infection of skin  |  3
HP:0000726  |  Dementia  |  3
HP:0004313  |  Decreased immunoglobulin level  |  3
HP:0012622  |  Chronic kidney disease  |  3
HP:0003128  |  Lactic acidosis  |  2
HP:0002015  |  Swallowing difficulty  |  2
HP:0012819  |  Myocarditis  |  2
HP:0001695  |  Cardiac arrest  |  2
HP:0001735  |  Acute pancreatitis  |  2
HP:0001622  |  Premature delivery  |  2
HP:0001746  |  Absent spleen  |  2
HP:0002019  |  Dyschezia  |  2
HP:0002789  |  Increased respiratory rate or depth of breathing  |  2
HP:0002014  |  Diarrhea  |  2
HP:0002315  |  Headaches  |  2
HP:0003470  |  Inability to move  |  2
HP:0012156  |  Hemophagocytosis  |  2
HP:0002239  |  Gastrointestinal hemorrhage  |  2
HP:0001082  |  Cholecystitis  |  2
HP:0030149  |  Cardiovascular shock  |  2
HP:0006970  |  Periventricular leukomalacia  |  2
HP:0001973  |  Autoimmune thrombocytopenia  |  2
HP:0002625  |  Blood clot in a deep vein  |  2
HP:0030746  |  Intraventricular hemorrhage  |  2
HP:0001396  |  Cholestasis  |  2
HP:0001541  |  Ascites  |  2
HP:0002153  |  Elevated serum potassium levels  |  2
HP:0002584  |  Intestinal hemorrhage  |  2
HP:0002093  |  progressive respiratory failure  |  2
HP:0011665  |  Takotsubo cardiomyopathy  |  2
HP:0005110  |  Atrial fibrillation  |  2
HP:0011951  |  Aspiration pneumonia  |  2
HP:0001643  |  Persistent ductus arteriosus  |  2
HP:0002958  |  Immune dysregulation  |  2
HP:0005543  |  Reduced protein C activity  |  2
HP:0006554  |  Acute hepatic failure  |  2
HP:0001250  |  Seizures  |  2
HP:0001254  |  Lethargy  |  2
HP:0002647  |  Aortic dissection  |  2
HP:0100598  |  Pulmonary oedema  |  1
HP:0000099  |  Glomerular nephritis  |  1
HP:0030242  |  Blood clot in portal vein  |  1
HP:0100843  |  Glioblastoma  |  1
HP:0040165  |  Periostitis  |  1
HP:0003201  |  Rhabdomyolysis  |  1
HP:0004756  |  Ventricular tachycardia  |  1
HP:0030150  |  Plasmacytosis  |  1
HP:0012592  |  Albuminuria  |  1
HP:0003324  |  Muscle weakness, diffuse  |  1
HP:0002883  |  Rapid breathing  |  1
HP:0002758  |  Osteoarthritis  |  1
HP:0007209  |  Facial paresis  |  1
HP:0011880  |  Acute disseminated intravascular coagulation  |  1
HP:0002032  |  Esophageal atresia  |  1
HP:0000365  |  Hearing impairment  |  1
HP:0001788  |  Premature rupture of membranes  |  1
HP:0100550  |  Rupture of tendons  |  1
HP:0011134  |  Mild fever  |  1
HP:0012416  |  Hypercarbia  |  1
HP:0000965  |  Livedo reticularis  |  1
HP:0000519  |  Cataracts, lenticular, bilateral  |  1
HP:0012594  |  High urine albumin levels  |  1
HP:0012490  |  Inflammation of fat tissue  |  1
HP:0002901  |  Hypocalcemia  |  1
HP:0001548  |  Overgrowth  |  1
HP:0011919  |  Pleural empyema  |  1
HP:0001701  |  Pericarditis  |  1
HP:0000024  |  Inflammation of the prostate  |  1
HP:0100806  |  Sepsis  |  1
HP:0001397  |  Hepatic steatosis  |  1
HP:0002480  |  Hepatic encephalopathy  |  1
HP:0001880  |  Eosinophilia  |  1
HP:0000989  |  pruritis  |  1
HP:0001824  |  Weight loss  |  1
HP:0001631  |  Atria septal defect  |  1
HP:0003270  |  Distended abdomen  |  1
HP:0100769  |  Synovitis  |  1
HP:0002133  |  Status epilepticus  |  1
HP:0001289  |  Confusion  |  1
HP:0001953  |  Diabetic ketosis  |  1
HP:0000126  |  Hydronephrosis  |  1
HP:0000112  |  Nephropathy  |  1
HP:0030148  |  Heart murmur  |  1
HP:0001409  |  Portal hypertension  |  1
HP:0010535  |  Sleep apnea  |  1
HP:0004308  |  Ventricular arrhythmia  |  1
HP:0200042  |  Skin ulcer  |  1
HP:0002590  |  Paralytic ileus  |  1
HP:0009830  |  Peripheral neuritis  |  1
HP:0002913  |  Myoglobinuria  |  1
HP:0005115  |  arrhythmias, Supraventricular  |  1
HP:0005575  |  Hemolytic-uremic syndrome  |  1
HP:0006510  |  Chronic obstructive pulmonary disease  |  1
HP:0000131  |  Uterine leiomyoma  |  1
HP:0003641  |  Hemoglobin in urine  |  1
HP:0007479  |  Nonbullous congenital ichthyosis  |  1
HP:0100862  |  Absent femoral head  |  1
HP:0005681  |  Juvenile idiopathic arthritis  |  1
HP:0012735  |  Coughing  |  1
HP:0002605  |  Hepatic necrosis  |  1
HP:0002375  |  Decreased spontaneous movement  |  1
HP:0001928  |  Abnormal blood coagulation studies  |  1
HP:0002092  |  Pulmonary artery hypertension  |  1
HP:0002107  |  Collapsed lung  |  1
HP:0030711  |  Hydrocolpos  |  1
HP:0002500  |  Leukoaraiosis  |  1
HP:0030448  |  Soft tissue sarcoma  |  1
HP:0001271  |  Polyneuropathy  |  1
HP:0200037  |  Skin vesicle  |  1
HP:0002719  |  infections, recurrent  |  1
HP:0002251  |  Hirschsprung megacolon  |  1
HP:0030853  |  Heterotaxy  |  1
HP:0012235  |  Drug-induced agranulocytosis  |  1
HP:0002652  |  Skeletal dysplasia  |  1
HP:0001907  |  Thromboembolic disease  |  1
HP:0002013  |  Emesis  |  1
HP:0001055  |  Erysipelas  |  1
HP:0002716  |  Lymph node hyperplasia  |  1
HP:0001342  |  Intracerebral hemorrhage  |  1
HP:0002475  |  Myelomeningocele  |  1
HP:0000787  |  Renal calculi  |  1
HP:0012189  |  Hodgkin disease  |  1
HP:0000518  |  Cataract  |  1
HP:0002039  |  Anorexia  |  1
HP:0001276  |  Hypertonia  |  1
HP:0000252  |  Small head circumference  |  1
HP:0100519  |  Anuria  |  1
HP:0001642  |  Pulmonic stenosis  |  1
HP:0000832  |  Primary hypothyroidism  |  1
HP:0001259  |  Coma  |  1
HP:0030774  |  Mitochondrial swelling  |  1
HP:0100520  |  Oliguria  |  1
HP:0011944  |  Small vessel vasculitis  |  1
HP:0000821  |  Underactive thyroid  |  1
HP:0001993  |  Ketoacidosis  |  1
HP:0200119  |  Acute liver inflammation  |  1
HP:0100590  |  Rectal fistula  |  1
HP:0012539  |  Non-Hodgkin lymphoma  |  1
HP:0001648  |  Cor pulmonale  |  1
HP:0002352  |  Leukoencephalopathy  |  1
HP:0003076  |  Glucosuria  |  1
HP:0004942  |  Aortic aneurysm  |  1
HP:0040154  |  Hidradenitis suppurativa  |  1
HP:0002059  |  Degeneration of cerebrum  |  1
HP:0000100  |  Nephrosis  |  1
HP:0000079  |  Urinary tract anomalies  |  1
HP:0002829  |  Arthralgias  |  1
HP:0002459  |  Dysautonomia  |  1
HP:0002783  |  Chronic lung infections  |  1
HP:0001343  |  Kernicterus  |  1
HP:0001263  |  Developmental retardation  |  1
HP:0001433  |  Enlarged liver and spleen  |  1
HP:0006775  |  Multiple myeloma  |  1
HP:0004755  |  Supraventricular tachycardia  |  1
HP:0006573  |  Acute fatty liver  |  1
HP:0100592  |  Peritoneal abscess  |  1
HP:0012210  |  Kidney malformation  |  1
HP:0002960  |  Autoimmune condition  |  1
HP:0012531  |  Pain  |  1
HP:0005943  |  Respiratory arrest  |  1
HP:0003281  |  Increased ferritin  |  1
HP:0002576  |  Intussusception  |  1
HP:0012213  |  Reduced creatinine clearance  |  1
HP:0002094  |  Dyspnea  |  1
HP:0003003  |  Colon cancer  |  1
HP:0100512  |  Vitamin D deficiency  |  1
Disease ID 1592
Disease septicemia
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:105)
C0009450  |  infection  |  175
C0948600  |  organ failure  |  168
C0021311  |  infections  |  105
C0032285  |  pneumonia  |  67
C0020649  |  hypotension  |  62
C0015967  |  fever  |  37
C0027947  |  neutropenia  |  36
C0476273  |  respiratory distress  |  28
C0231303  |  distress  |  25
C0012739  |  disseminated intravascular coagulation  |  25
C0004623  |  bacterial infection  |  24
C0031154  |  peritonitis  |  24
C1839611  |  n syndrome  |  23
C0342953  |  organ dysfunction syndrome  |  23
C1704437  |  respiratory distress syndrome  |  23
C0426768  |  o sign  |  22
C0021079  |  immunosuppression  |  21
C0040034  |  thrombocytopenia  |  21
C0035078  |  renal failure  |  19
C0035222  |  acute respiratory distress syndrome  |  19
C0011847  |  diabetes  |  17
C0005779  |  coagulopathy  |  17
C0022660  |  acute renal failure  |  16
C0025289  |  meningitis  |  13
C0040053  |  thrombosis  |  12
C0022116  |  ischemia  |  12
C0011570  |  depression  |  11
C1145670  |  respiratory failure  |  11
C0085584  |  encephalopathy  |  11
C0242966  |  systemic inflammatory response syndrome  |  11
C0008495  |  chorioamnionitis  |  10
C0016169  |  fistula  |  9
C0020672  |  hypothermia  |  8
C0020456  |  hyperglycemia  |  8
C0262405  |  brain dysfunction  |  8
C0029443  |  osteomyelitis  |  7
C0856169  |  endothelial dysfunction  |  7
C0022346  |  jaundice  |  7
C0796095  |  c syndrome  |  6
C0018801  |  heart failure  |  6
C0020538  |  hypertension  |  6
C0022672  |  acute tubular necrosis  |  6
C0020598  |  hypoglycemia  |  5
C0001623  |  adrenal insufficiency  |  5
C1565489  |  renal insufficiency  |  5
C0030305  |  pancreatitis  |  5
C0948268  |  hemodynamic instability  |  5
C0878544  |  cardiomyopathy  |  5
C0026846  |  muscle wasting  |  5
C0037284  |  skin lesions  |  4
C0021053  |  immune dysfunction  |  4
C0012739  |  disseminated intravascular coagulation (dic)  |  4
C0919747  |  cytokine storm  |  4
C0035222  |  adult respiratory distress syndrome  |  4
C0039231  |  tachycardia  |  4
C0085605  |  hepatic failure  |  4
C0085650  |  purpura fulminans  |  4
C0000833  |  abscess  |  4
C0013568  |  ecthyma  |  4
C0002766  |  analgesia  |  4
C0004610  |  bacteremia  |  3
C0020433  |  hyperbilirubinemia  |  3
C0021079  |  immune suppression  |  3
C0034186  |  pyelonephritis  |  3
C0744471  |  gram-negative bacteremia  |  3
C0235574  |  intravascular hemolysis  |  3
C0032285  |  lung inflammation  |  3
C0014118  |  endocarditis  |  3
C0341697  |  impaired renal function  |  3
C0026846  |  muscle atrophy  |  2
C1739395  |  takotsubo cardiomyopathy  |  2
C0021308  |  infarction  |  2
C0008370  |  cholestasis  |  2
C0085605  |  liver failure  |  2
C0398625  |  protein c deficiency  |  2
C0005779  |  coagulation disorders  |  2
C0001125  |  lactic acidosis  |  2
C0267752  |  acute suppurative peritonitis  |  2
C0341697  |  renal impairment  |  2
C0035229  |  respiratory insufficiency  |  2
C0020542  |  pulmonary hypertension  |  1
C0026848  |  myopathies  |  1
C0015645  |  fasciitis  |  1
C0022660  |  acute kidney failure  |  1
C0005779  |  coagulopathies  |  1
C0021053  |  immune disorders  |  1
C0262405  |  cerebral dysfunction  |  1
C0744471  |  gram-negative bacteraemia  |  1
C0023890  |  liver cirrhosis  |  1
C0037285  |  skin manifestations  |  1
C0014236  |  endophthalmitis  |  1
C0036981  |  endotoxic shock  |  1
C0001127  |  hypercapnic acidosis  |  1
C0034063  |  pulmonary edema  |  1
C0149778  |  soft tissue infections  |  1
C0034155  |  thrombotic thrombocytopenic purpura  |  1
C0235574  |  intravascular haemolysis  |  1
C0019270  |  hernias  |  1
C0039240  |  supraventricular tachycardia  |  1
C0006666  |  calciphylaxis  |  1
C1282231  |  endogenous endophthalmitis  |  1
C0018799  |  heart disease  |  1
C0026764  |  multiple myeloma  |  1
C0015695  |  fatty liver  |  1
C0853892  |  catabolic state  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:143)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1059702177858513654IRAK1umls:C0036690BeFreeWe previously described that a commonly occurring IRAK-1 variant haplotype, containing amino acid changes from serine to phenylalanine at position 196 and from leucine to serine at position 532, is associated with increased activation of NF-kappaB in LPS-stimulated neutrophils from patients with sepsis-induced acute lung injury and also higher mortality and more severe clinical outcomes in such patients.0.0013572092007IRAK1X154018741AG
rs1059702177858513654IRAK1umls:C0243026BeFreeWe previously described that a commonly occurring IRAK-1 variant haplotype, containing amino acid changes from serine to phenylalanine at position 196 and from leucine to serine at position 532, is associated with increased activation of NF-kappaB in LPS-stimulated neutrophils from patients with sepsis-induced acute lung injury and also higher mortality and more severe clinical outcomes in such patients.0.0060912732007IRAK1X154018741AG
rs1059703177858513654IRAK1umls:C0036690BeFreeWe previously described that a commonly occurring IRAK-1 variant haplotype, containing amino acid changes from serine to phenylalanine at position 196 and from leucine to serine at position 532, is associated with increased activation of NF-kappaB in LPS-stimulated neutrophils from patients with sepsis-induced acute lung injury and also higher mortality and more severe clinical outcomes in such patients.0.0013572092007IRAK1X154013378GA
rs1059703177858513654IRAK1umls:C0243026BeFreeWe previously described that a commonly occurring IRAK-1 variant haplotype, containing amino acid changes from serine to phenylalanine at position 196 and from leucine to serine at position 532, is associated with increased activation of NF-kappaB in LPS-stimulated neutrophils from patients with sepsis-induced acute lung injury and also higher mortality and more severe clinical outcomes in such patients.0.0060912732007IRAK1X154013378GA
rs1061170203516163075CFHumls:C0243026BeFreeHomozygosity for the complement factor H Y402H polymorphism, which is thought to reduce complement inhibition, was associated with less frequent SIRS/sepsis (the adjusted odds ratio for the homozygous variant complement factor H Y402H [CC] carriers was 0.3, 95% confidence interval, 0.1-0.7, p = .005).0.0810857672010CFH1196690107CT
rs1061170203516163075CFHumls:C0036690BeFreeHomozygosity for the complement factor H Y402H polymorphism, which is thought to reduce complement inhibition, was associated with less frequent SIRS/sepsis (the adjusted odds ratio for the homozygous variant complement factor H Y402H [CC] carriers was 0.3, 95% confidence interval, 0.1-0.7, p = .005).0.0010857672010CFH1196690107CT
rs1143643250001793553IL1Bumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0035287442014IL1B2112830725CT
rs1143643250001794325MMP16umls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0002714422014IL1B2112830725CT
rs114364325000179671BPIumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0008143262014IL1B2112830725CT
rs1143643250001793553IL1Bumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.1028223182014IL1B2112830725CT
rs114364325000179671BPIumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0058198312014IL1B2112830725CT
rs1143643250001794325MMP16umls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0026384742014IL1B2112830725CT
rs114659962226696823643LY96umls:C0243026BeFreeAmong the three htSNPs of the entire MD-2 gene, only the rs11465996 might be used as relevant risk estimate for the development of sepsis and MOD syndrome in patients with major trauma.0.0032672342012LY96873989727CG
rs114659962226696823643LY96umls:C0036690BeFreeAmong the three htSNPs of the entire MD-2 gene, only the rs11465996 might be used as relevant risk estimate for the development of sepsis and MOD syndrome in patients with major trauma.0.0005428842012LY96873989727CG
rs11536889249507117099TLR4umls:C0243026BeFreeThe regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients.0.2435391152014TLR49117715853GC
rs11536889249507117099TLR4umls:C0036690BeFreeThe regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients.0.0097719072014TLR49117715853GC
rs11568821244639785133PDCD1umls:C0243026BeFreeNinety-day survival rate of patients with sepsis relates to programmed cell death 1 genetic polymorphism rs11568821.0.0005428842014PDCD1;LOC1053739772241851760CT,G
rs11568821244639785133PDCD1umls:C0036690BeFreeNinety-day survival rate of patients with sepsis relates to programmed cell death 1 genetic polymorphism rs11568821.0.0005428842014PDCD1;LOC1053739772241851760CT,G
rs121917864182491337097TLR2umls:C0243026BeFreeSingle nucleotide polymorphisms (SNPs) Arg753Gln and Arg677Trp affect TLR2 responsiveness and may contribute to the course of sepsis, which is associated with substantial morbidity and mortality during intensive care treatment.0.0999024712008TLR24153704936CT
rs121917864182491337097TLR2umls:C0036690BeFreeSingle nucleotide polymorphisms (SNPs) Arg753Gln and Arg677Trp affect TLR2 responsiveness and may contribute to the course of sepsis, which is associated with substantial morbidity and mortality during intensive care treatment.0.0054288372008TLR24153704936CT
rs12652255223103534488MSX2umls:C0243026GAD[Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis.]0.0023670322013NA5175334092CA
rs1327307322310353137814NKX2-6umls:C0243026GAD[Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis.]0.0023670322013LOC101929258823726713GT
rs1446725092279801754210TREM1umls:C0243026BeFreeOf the three tested TREM-1 SNPs (rs144672509, rs2234237, and rs2234246), only rs2234237 (Ser25Thr) was significantly associated with sepsis prognosis in three inheritance models (p < 0.05).0.0032573022012TREM1641282512GA
rs1446725092279801754210TREM1umls:C0036690BeFreeOf the three tested TREM-1 SNPs (rs144672509, rs2234237, and rs2234246), only rs2234237 (Ser25Thr) was significantly associated with sepsis prognosis in three inheritance models (p < 0.05).0.0032573022012TREM1641282512GA
rs1799946250001794325MMP16umls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0002714422014DEFB186877909CT
rs1799946250001794325MMP16umls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0026384742014DEFB186877909CT
rs1799946250001793553IL1Bumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.1028223182014DEFB186877909CT
rs1799946250001793553IL1Bumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0035287442014DEFB186877909CT
rs179994625000179671BPIumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0008143262014DEFB186877909CT
rs179994625000179671BPIumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0058198312014DEFB186877909CT
rs1799983252396552147F2umls:C0243026BeFreeSepsis independently associated with HF, increased NOx, peripheral neutrophils, and fibrinogen levels, decreased prothrombin and the presence of the NOS3 (E298D) and NOS2A (exon 22) SNPs.0.0805428842014NOS37150999023TG
rs1799983252396554843NOS2umls:C0243026BeFreeEndothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.0.2013572092014NOS37150999023TG
rs1799983252396552147F2umls:C0036690BeFreeSepsis independently associated with HF, increased NOx, peripheral neutrophils, and fibrinogen levels, decreased prothrombin and the presence of the NOS3 (E298D) and NOS2A (exon 22) SNPs.0.0005428842014NOS37150999023TG
rs1799983252396554846NOS3umls:C0243026BeFreeEndothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.0.125548392014NOS37150999023TG
rs179998325239655339345NANOS2umls:C0036690BeFreeEndothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.0.0005428842014NOS37150999023TG
rs1799983252396554846NOS3umls:C0036690BeFreeEndothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.0.0008143262014NOS37150999023TG
rs179998325239655339345NANOS2umls:C0243026BeFreeEndothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.0.0005428842014NOS37150999023TG
rs1799983188277454846NOS3umls:C0243026BeFreeThe eNOS gene polymorphism at position 894 (G>T, Glu298Asp) resulting in T allele has been studied in the context of vascular diseases, but its role in sepsis has not yet been explored.0.125548392009NOS37150999023TG
rs1799983188277454846NOS3umls:C0036690BeFreeThe eNOS gene polymorphism at position 894 (G>T, Glu298Asp) resulting in T allele has been studied in the context of vascular diseases, but its role in sepsis has not yet been explored.0.0008143262009NOS37150999023TG
rs1799983252396554843NOS2umls:C0036690BeFreeEndothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.0.0013572092014NOS37150999023TG
rs1800896204636185320PLA2G2Aumls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0034527992010IL101206773552TC
rs1800896204636185320PLA2G2Aumls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0010857672010IL101206773552TC
rs1800896204636187097TLR2umls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0054288372010IL101206773552TC
rs1800896204636187097TLR2umls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0999024712010IL101206773552TC
rs1829975223103535937RBMS1umls:C0243026GAD[Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis.]0.0023670322013NA2160928658CT
rs187084216339477124TNFumls:C0036690BeFreeBoth rs187084 and rs352162 were significantly associated with TNF-α production by peripheral blood leucocytes in response to bacterial DNA stimulation and a higher sepsis morbidity rate in patients with major trauma.0.0211724662011TLR9352227015AG
rs187084216339477124TNFumls:C0243026BeFreeBoth rs187084 and rs352162 were significantly associated with TNF-α production by peripheral blood leucocytes in response to bacterial DNA stimulation and a higher sepsis morbidity rate in patients with major trauma.0.2861542842011TLR9352227015AG
rs1891320204636187097TLR2umls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0999024712010NA119970618CT
rs1891320204636185320PLA2G2Aumls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0034527992010NA119970618CT
rs1891320204636185320PLA2G2Aumls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0010857672010NA119970618CT
rs1891320204636187097TLR2umls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0054288372010NA119970618CT
rs2069912184967165624PROCumls:C0243026GAD[Protein C rs2069912 C allele is associated with increased mortality from severe sepsis in North Americans of East Asian ancestry.]0.1280012982008PROC2127420615TC
rs21238824582067117289TAGAPumls:C0243026BeFreeWe have previously suggested a correlation between the TAGAP-associated single nucleotide polymorphism rs212388 and protection from anal sepsis in Crohn's disease (CD) patients.0.0005428842014NA6159069404CT
rs21238824582067117289TAGAPumls:C0036690BeFreeWe have previously suggested a correlation between the TAGAP-associated single nucleotide polymorphism rs212388 and protection from anal sepsis in Crohn's disease (CD) patients.0.0005428842014NA6159069404CT
rs22342372279801754210TREM1umls:C0243026BeFreeOf the three tested TREM-1 SNPs (rs144672509, rs2234237, and rs2234246), only rs2234237 (Ser25Thr) was significantly associated with sepsis prognosis in three inheritance models (p < 0.05).0.0032573022012TREM1641282728TA
rs22342372279801754210TREM1umls:C0036690BeFreeOf the three tested TREM-1 SNPs (rs144672509, rs2234237, and rs2234246), only rs2234237 (Ser25Thr) was significantly associated with sepsis prognosis in three inheritance models (p < 0.05).0.0032573022012TREM1641282728TA
rs22342462279801754210TREM1umls:C0036690BeFreeOf the three tested TREM-1 SNPs (rs144672509, rs2234237, and rs2234246), only rs2234237 (Ser25Thr) was significantly associated with sepsis prognosis in three inheritance models (p < 0.05).0.0032573022012TREM1641276002CT
rs22342462279801754210TREM1umls:C0243026BeFreeOf the three tested TREM-1 SNPs (rs144672509, rs2234237, and rs2234246), only rs2234237 (Ser25Thr) was significantly associated with sepsis prognosis in three inheritance models (p < 0.05).0.0032573022012TREM1641276002CT
rs266434925000179671BPIumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0008143262014MMP16888077054GA
rs2664349250001793553IL1Bumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0035287442014MMP16888077054GA
rs2664349250001793553IL1Bumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.1028223182014MMP16888077054GA
rs2664349250001794325MMP16umls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0026384742014MMP16888077054GA
rs2664349250001794325MMP16umls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0002714422014MMP16888077054GA
rs266434925000179671BPIumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0058198312014MMP16888077054GA
rs291016424701036406938MIR146Aumls:C0243026BeFreeOur study has analyzed the association of sepsis with two functional miR-146a gene SNPs rs2910164 G/C and rs57095329 A/G in a Chinese Han population (226 sepsis cases; 206 healthy controls).0.0008143262014LOC285628;MIR146A5160485411CG
rs291016424701036406938MIR146Aumls:C0036690BeFreeOur study has analyzed the association of sepsis with two functional miR-146a gene SNPs rs2910164 G/C and rs57095329 A/G in a Chinese Han population (226 sepsis cases; 206 healthy controls).0.0008143262014LOC285628;MIR146A5160485411CG
rs345574122545480423495TNFRSF13Bumls:C0036690BeFreeMoreover, carriers of TACI-C104R displayed an undiagnosed mild to moderate hypogammaglobulinemia along with a significantly lower survival rate in the ICU, although lethal events were not attributed to sepsis.0.0002714422014TNFRSF13B1716948873AG
rs345574122545480423495TNFRSF13Bumls:C0243026BeFreeMoreover, carriers of TACI-C104R displayed an undiagnosed mild to moderate hypogammaglobulinemia along with a significantly lower survival rate in the ICU, although lethal events were not attributed to sepsis.0.0002714422014TNFRSF13B1716948873AG
rs352162216339477124TNFumls:C0036690BeFreeBoth rs187084 and rs352162 were significantly associated with TNF-α production by peripheral blood leucocytes in response to bacterial DNA stimulation and a higher sepsis morbidity rate in patients with major trauma.0.0211724662011NA352218953TC
rs352162216339477124TNFumls:C0243026BeFreeBoth rs187084 and rs352162 were significantly associated with TNF-α production by peripheral blood leucocytes in response to bacterial DNA stimulation and a higher sepsis morbidity rate in patients with major trauma.0.2861542842011NA352218953TC
rs375912921427539362AQP5umls:C0036690BeFreeBecause the aquaporin (AQP) 5 promoter -1364A/C polymorphism is associated with altered AQP5 expression, this association could have an impact on key mechanisms in sepsis, such as cell migration, activity of the rennin-angiotensin- aldosterone system (RAAS), and water transport across biologic membranes.0.0005428842011AQP5;LOC1019273181249960654AC
rs375912921427539362AQP5umls:C0243026BeFreeBecause the aquaporin (AQP) 5 promoter -1364A/C polymorphism is associated with altered AQP5 expression, this association could have an impact on key mechanisms in sepsis, such as cell migration, activity of the rennin-angiotensin- aldosterone system (RAAS), and water transport across biologic membranes.0.0005428842011AQP5;LOC1019273181249960654AC
rs3804099204636187097TLR2umls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0999024712010TLR24153703504TC
rs3804099204636185320PLA2G2Aumls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0010857672010TLR24153703504TC
rs3804099204636187097TLR2umls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0054288372010TLR24153703504TC
rs3804099204636185320PLA2G2Aumls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0034527992010TLR24153703504TC
rs435818825000179671BPIumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0058198312014BPI;LOC1053726122038318446GA
rs4358188250001793553IL1Bumls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.1028223182014BPI;LOC1053726122038318446GA
rs4358188250001794325MMP16umls:C0243026BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0026384742014BPI;LOC1053726122038318446GA
rs435818825000179671BPIumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0008143262014BPI;LOC1053726122038318446GA
rs4358188250001794325MMP16umls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0002714422014BPI;LOC1053726122038318446GA
rs4358188250001793553IL1Bumls:C0036690BeFreeGenotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both).0.0035287442014BPI;LOC1053726122038318446GA
rs47237382231035383930STARD3NLumls:C0243026GAD[Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis.]0.0023670322013STARD3NL738201307AG
rs4880254977382876GPX1umls:C0036690BeFreeEvaluating the subgroup of 293 ICU patients with sepsis, a pooled analysis including two genetic variants GPx1 and SOD2 (47C>T SNP, rs4880; protein variant in MnSOD: Ala-9Val) showed a significant difference in relation to progression to septic shock.0.0002714422014SOD26159692840AG
rs4880254977382876GPX1umls:C0243026BeFreeEvaluating the subgroup of 293 ICU patients with sepsis, a pooled analysis including two genetic variants GPx1 and SOD2 (47C>T SNP, rs4880; protein variant in MnSOD: Ala-9Val) showed a significant difference in relation to progression to septic shock.0.0002714422014SOD26159692840AG
rs491951024743625693193MIR608umls:C0036690BeFreeOur results indicate that the rs4919510G/C SNP in hsa-mir-608 may be a prognostic biomarker for sepsis in patients with major trauma.0.0002714422015SEMA4G;MIR60810100975021CG
rs491951024743625693193MIR608umls:C0243026BeFreeOur results indicate that the rs4919510G/C SNP in hsa-mir-608 may be a prognostic biomarker for sepsis in patients with major trauma.0.0002714422015SEMA4G;MIR60810100975021CG
rs49711622615879100506742CASP12umls:C0036690BeFreeIn humans, the C allele at CASP12 rs497116 has been associated with an increased risk of sepsis.0.0019000932012CASP1211104892390AG
rs49711622615879100506742CASP12umls:C0243026BeFreeIn humans, the C allele at CASP12 rs497116 has been associated with an increased risk of sepsis.0.0019000932012CASP1211104892390AG
rs4986790180342447099TLR4umls:C0036690BeFreeTwo commonly occurring SNPs in the human TLR4 gene (Asp299Gly and Thr399Ile) have been shown to be associated with increased risk of Gram-negative bacteremia in sepsis patients and with susceptibility to inflammatory bowel disease.0.0097719072008TLR49117713024AG
rs4986790124041747099TLR4umls:C0036690BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0097719072002TLR49117713024AG
rs4986790124041744695NDUFA2umls:C0036690BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0051573962002TLR49117713024AG
rs498679012404174929CD14umls:C0036690BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0051573962002TLR49117713024AG
rs4986790124041747099TLR4umls:C0243026BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.2435391152002TLR49117713024AG
rs4986790180342447099TLR4umls:C0243026BeFreeTwo commonly occurring SNPs in the human TLR4 gene (Asp299Gly and Thr399Ile) have been shown to be associated with increased risk of Gram-negative bacteremia in sepsis patients and with susceptibility to inflammatory bowel disease.0.2435391152008TLR49117713024AG
rs498679012404174929CD14umls:C0243026BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0433013492002TLR49117713024AG
rs4986790219682867099TLR4umls:C0036690BeFreeIn conclusion, differences in distribution of TLR4 polymorphisms Asp299Gly and Thr399Ile in European populations are most likely due to a combination of population migration events combined with selection due to sepsis.0.0097719072012TLR49117713024AG
rs4986790155204047099TLR4umls:C0243026GAD[Candidate single nucleotide polymorphisms (SNPs) within bacterial recognition (TLR4 +896, CD14 -159) and inflammatory response (TNF-alpha -308, IL-1beta -31, IL-6 -174) loci were evaluated for association with increased risk for severe sepsis (sepsis plus organ dysfunction or septic shock) and mortality.]0.2435391152004TLR49117713024AG
rs4986790254275607099TLR4umls:C0036690BeFreeFurthermore, the cosegregating TLR4 polymorphisms Asp299Gly and Thr399Ile were independent risk factors for the development of both sepsis and pneumonia (OR: 3.55; 95% CI: 1.21-10.4, P=0.021 and OR: 3.57, 95% CI: 1.3-9.86, P=0.014, respectively).0.0097719072014TLR49117713024AG
rs4986790124041744695NDUFA2umls:C0243026BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0054288372002TLR49117713024AG
rs4986790254548047099TLR4umls:C0036690BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0097719072014TLR49117713024AG
rs4986790225376747099TLR4umls:C0243026BeFreeLack of association between TLR4 Asp299Gly and Thr399Ile polymorphisms and sepsis susceptibility: a meta-analysis.0.2435391152012TLR49117713024AG
rs4986790254548047099TLR4umls:C0243026BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.2435391152014TLR49117713024AG
rs4986790225376747099TLR4umls:C0036690BeFreeLack of association between TLR4 Asp299Gly and Thr399Ile polymorphisms and sepsis susceptibility: a meta-analysis.0.0097719072012TLR49117713024AG
rs498679025454804115650TNFRSF13Cumls:C0243026BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0002714422014TLR49117713024AG
rs4986790254275607099TLR4umls:C0243026BeFreeFurthermore, the cosegregating TLR4 polymorphisms Asp299Gly and Thr399Ile were independent risk factors for the development of both sepsis and pneumonia (OR: 3.55; 95% CI: 1.21-10.4, P=0.021 and OR: 3.57, 95% CI: 1.3-9.86, P=0.014, respectively).0.2435391152014TLR49117713024AG
rs498679025454804115650TNFRSF13Cumls:C0036690BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0002714422014TLR49117713024AG
rs4986790219682867099TLR4umls:C0243026BeFreeIn conclusion, differences in distribution of TLR4 polymorphisms Asp299Gly and Thr399Ile in European populations are most likely due to a combination of population migration events combined with selection due to sepsis.0.2435391152012TLR49117713024AG
rs4986791124041744695NDUFA2umls:C0243026BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0054288372002TLR49117713324CT
rs4986791124041747099TLR4umls:C0243026BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.2435391152002TLR49117713324CT
rs4986791124041744695NDUFA2umls:C0036690BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0051573962002TLR49117713324CT
rs4986791225376747099TLR4umls:C0243026BeFreeLack of association between TLR4 Asp299Gly and Thr399Ile polymorphisms and sepsis susceptibility: a meta-analysis.0.2435391152012TLR49117713324CT
rs498679112404174929CD14umls:C0036690BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0051573962002TLR49117713324CT
rs4986791219682867099TLR4umls:C0036690BeFreeIn conclusion, differences in distribution of TLR4 polymorphisms Asp299Gly and Thr399Ile in European populations are most likely due to a combination of population migration events combined with selection due to sepsis.0.0097719072012TLR49117713324CT
rs4986791254548047099TLR4umls:C0243026BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.2435391152014TLR49117713324CT
rs4986791180342447099TLR4umls:C0036690BeFreeTwo commonly occurring SNPs in the human TLR4 gene (Asp299Gly and Thr399Ile) have been shown to be associated with increased risk of Gram-negative bacteremia in sepsis patients and with susceptibility to inflammatory bowel disease.0.0097719072008TLR49117713324CT
rs4986791124041747099TLR4umls:C0036690BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0097719072002TLR49117713324CT
rs4986791225376747099TLR4umls:C0036690BeFreeLack of association between TLR4 Asp299Gly and Thr399Ile polymorphisms and sepsis susceptibility: a meta-analysis.0.0097719072012TLR49117713324CT
rs4986791254548047099TLR4umls:C0036690BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0097719072014TLR49117713324CT
rs498679112404174929CD14umls:C0243026BeFreeOur study investigated the association between TLR4 mutations (Asp299Gly and Thr399Ile) and CD14 polymorphism(s) with outcome in an intensive care unit (ICU) population at risk for sepsis.0.0433013492002TLR49117713324CT
rs498679125454804115650TNFRSF13Cumls:C0243026BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0002714422014TLR49117713324CT
rs4986791254275607099TLR4umls:C0036690BeFreeFurthermore, the cosegregating TLR4 polymorphisms Asp299Gly and Thr399Ile were independent risk factors for the development of both sepsis and pneumonia (OR: 3.55; 95% CI: 1.21-10.4, P=0.021 and OR: 3.57, 95% CI: 1.3-9.86, P=0.014, respectively).0.0097719072014TLR49117713324CT
rs4986791180342447099TLR4umls:C0243026BeFreeTwo commonly occurring SNPs in the human TLR4 gene (Asp299Gly and Thr399Ile) have been shown to be associated with increased risk of Gram-negative bacteremia in sepsis patients and with susceptibility to inflammatory bowel disease.0.2435391152008TLR49117713324CT
rs4986791254275607099TLR4umls:C0243026BeFreeFurthermore, the cosegregating TLR4 polymorphisms Asp299Gly and Thr399Ile were independent risk factors for the development of both sepsis and pneumonia (OR: 3.55; 95% CI: 1.21-10.4, P=0.021 and OR: 3.57, 95% CI: 1.3-9.86, P=0.014, respectively).0.2435391152014TLR49117713324CT
rs4986791219682867099TLR4umls:C0243026BeFreeIn conclusion, differences in distribution of TLR4 polymorphisms Asp299Gly and Thr399Ile in European populations are most likely due to a combination of population migration events combined with selection due to sepsis.0.2435391152012TLR49117713324CT
rs498679125454804115650TNFRSF13Cumls:C0036690BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0002714422014TLR49117713324CT
rs5709532924701036406938MIR146Aumls:C0036690BeFreeOur study has analyzed the association of sepsis with two functional miR-146a gene SNPs rs2910164 G/C and rs57095329 A/G in a Chinese Han population (226 sepsis cases; 206 healthy controls).0.0008143262014LOC2856285160467840AG
rs5709532924701036406938MIR146Aumls:C0243026BeFreeOur study has analyzed the association of sepsis with two functional miR-146a gene SNPs rs2910164 G/C and rs57095329 A/G in a Chinese Han population (226 sepsis cases; 206 healthy controls).0.0008143262014LOC2856285160467840AG
rs5743708182491337097TLR2umls:C0036690BeFreeSingle nucleotide polymorphisms (SNPs) Arg753Gln and Arg677Trp affect TLR2 responsiveness and may contribute to the course of sepsis, which is associated with substantial morbidity and mortality during intensive care treatment.0.0054288372008TLR24153705165GA
rs5743708182491337097TLR2umls:C0243026BeFreeSingle nucleotide polymorphisms (SNPs) Arg753Gln and Arg677Trp affect TLR2 responsiveness and may contribute to the course of sepsis, which is associated with substantial morbidity and mortality during intensive care treatment.0.0999024712008TLR24153705165GA
rs5744105204636187097TLR2umls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0054288372010TLR51223142735GC
rs5744105204636185320PLA2G2Aumls:C0036690BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0010857672010TLR51223142735GC
rs5744105204636187097TLR2umls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0999024712010TLR51223142735GC
rs5744105204636185320PLA2G2Aumls:C0243026BeFreePolymorphisms in TLR2 (rs3804099), TLR5 (rs5744105), IL10 (rs1800896), and PLA2G2A (rs1891320) genes were associated with sepsis.0.0034527992010TLR51223142735GC
rs6025202022262153F5umls:C0243026GAD[FVL carrier status did not predict either susceptibility to or outcome from Gram negative, Escherichia coli or Streptococcus pneumoniae sepsis.]0.0260136082010F51169549811CT
rs77874543254548047099TLR4umls:C0036690BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0097719072014TNFRSF13C2241926712GC
rs7787454325454804115650TNFRSF13Cumls:C0036690BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0002714422014TNFRSF13C2241926712GC
rs7787454325454804115650TNFRSF13Cumls:C0243026BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.0002714422014TNFRSF13C2241926712GC
rs77874543254548047099TLR4umls:C0243026BeFreeInterestingly, TLR4-D299G, TLR4-T399I and BAFFR-P21R carriage was associated with a lower risk of ICU-acquired sepsis.0.2435391152014TNFRSF13C2241926712GC
rs97702421655561510135NAMPTumls:C0243026BeFreeDNA sequencing identified two single nucleotide polymorphisms (SNPs) in the PBEF promoter (T-1001G, C-1543T), which were genotyped in a Caucasian cohort of sepsis-associated ALI patients.0.0005428842005NAMPT7106285885CA
rs97702421655561510135NAMPTumls:C0036690BeFreeDNA sequencing identified two single nucleotide polymorphisms (SNPs) in the PBEF promoter (T-1001G, C-1543T), which were genotyped in a Caucasian cohort of sepsis-associated ALI patients.0.0005428842005NAMPT7106285885CA
rs97702421687763410135NAMPTumls:C0243026BeFreePBEF protein levels were elevated in human bronchoalveolar lavage and serum samples from patients with ALI, and DNA sequencing identified two single nucleotide polymorphisms in the PBEF promoter (T-1001G, C-1543T) that were overrepresented in patients with sepsis-induced ALI.0.0005428842006NAMPT7106285885CA
rs97702421687763410135NAMPTumls:C0036690BeFreePBEF protein levels were elevated in human bronchoalveolar lavage and serum samples from patients with ALI, and DNA sequencing identified two single nucleotide polymorphisms in the PBEF promoter (T-1001G, C-1543T) that were overrepresented in patients with sepsis-induced ALI.0.0005428842006NAMPT7106285885CA
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:8)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
1239075714rs1915279AGrs1915279223103532.00E-06GG vs. not GGNANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tA
2161785169rs1829975CTrs1829975223103536.00E-06AG vs. not AGNANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tG
5174761095rs12652255CArs12652255223103538.00E-06CC vs. not CCNANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tC
738240908rs4723738AGrs4723738223103536.00E-06AG vs. not AGNANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tA
746392567rs17513961TGrs17513961223103531.00E-07TT vs. not TTNANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tT
823584226rs13273073GTrs13273073223103537.00E-06GT vs. not GTNANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tG
1674076252rs2716601AGrs2716601223103531.00E-06TT vs. not TTNANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tC
2241042091rs12159200ACrs12159200223103536.00E-07AA vs. not AANANA1,446 individualsNOPOP(1446)ALL(1446)NOPOP(1446)ALL(1446)Treatment response for severe sepsisHPOID:0100806SepsisDOID:104bacterial infectious diseaseD018746Systemic Inflammatory Response SyndromeNANABacterial infectionNAMulticenter StudyResearch Support, Non-U.S. Gov'tC
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:30)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0036690amikacinD00058337517-28-5sepsisMESH:D018805therapeutic10223137
C0036690ampicillinD00066769-53-4sepsisMESH:D018805therapeutic3316564
C0036690bleomycinD00176111056-06-7sepsisMESH:D018805marker/mechanism10526668
C0036690capsaicinD002211404-86-4sepsisMESH:D018805therapeutic12888332
C0036690carbenicillinD0022284697-36-3sepsisMESH:D018805therapeutic4850936
C0036690cefotaximeD00243963527-52-6sepsisMESH:D018805therapeutic19321684
C0036690chloramphenicolD00270156-75-7sepsisMESH:D018805marker/mechanism6071896
C0036690ciprofloxacinD00293985721-33-1sepsisMESH:D018805therapeutic11145498
C0036690colchicineD00307864-86-8sepsisMESH:D018805marker/mechanism17505274
C0036690cyclophosphamideD00352050-18-0sepsisMESH:D018805marker/mechanism10526668
C0036690cisplatinD00294515663-27-1sepsisMESH:D018805marker/mechanism12110496
C0036690epirubicinD01525156420-45-2sepsisMESH:D018805marker/mechanism10526668
C0036690erythromycinD004917114-07-8sepsisMESH:D018805therapeutic947847
C0036690fluorouracilD00547251-21-8sepsisMESH:D018805marker/mechanism11822757
C0036690leucovorinD0029551958/5/9sepsisMESH:D018805marker/mechanism11822757
C0036690ifosfamideD0070693778-73-2sepsisMESH:D018805marker/mechanism3114435
C0036690indomethacinD00721353-86-1sepsisMESH:D018805marker/mechanism12632374
C0036690linezolidD000069349-sepsisMESH:D018805therapeutic19231981
C0036690melphalanD008558148-82-3sepsisMESH:D018805marker/mechanism10656432
C0036690methotrexateD0087271959/5/2sepsisMESH:D018805marker/mechanism8779788
C0036690nafcillinD009254147-52-4sepsisMESH:D018805therapeutic448989
C0036690nitric oxideD00956910102-43-9sepsisMESH:D018805marker/mechanism10632965
C0036690norepinephrineD00963851-41-2sepsisMESH:D018805therapeutic21519229
C0036690paclitaxelD017239-sepsisMESH:D018805marker/mechanism12110496
C0036690epoprostenolD01146435121-78-9sepsisMESH:D018805marker/mechanism3552006
C0036690rifampinD01229313292-46-1sepsisMESH:D018805therapeutic2488482
C0036690vancomycinD0146401404-90-6sepsisMESH:D018805therapeutic16407668
C0036690vinblastineD014747865-21-4sepsisMESH:D018805marker/mechanism4688040
C0036690vincristineD014750-sepsisMESH:D018805marker/mechanism4631913
C0036690vinorelbineC03085271486-22-1sepsisMESH:D018805marker/mechanism11745280
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)